POUCH, ILEAL

Clinical trials for POUCH, ILEAL explained in plain language.

Never miss a new study

Get alerted when new POUCH, ILEAL trials appear

Sign up with your email to follow new studies for POUCH, ILEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Terminated 1

New drug trial aims to ease pouch disorder symptoms

Disease control Recruiting now

This study tests whether mirikizumab can reduce symptoms of chronic pouch inflammation in 25 adults. Participants receive the drug every 4 weeks for a year and track their symptoms. The goal is to see if it helps control the condition without needing ongoing antibiotics.

Matched conditions: POUCH, ILEAL

Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

POUCH, ILEAL

Get alerted when new POUCH, ILEAL trials appear

New drug trial aims to ease pouch disorder symptoms